FDA delays cost Americans trillions and slow lifesaving drugs, new report says

FDA delays cost Americans trillions and slow lifesaving drugs, new report says

Economist Tomas Philipson warns China's faster clinical trial system could lure investment away from the US...

Redirecting to full article...